Sanofi (SAN) News Today €86.80 -0.88 (-1.00%) As of 06/13/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSustainabilityBuy This Stock SAN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZenecaJune 10, 2025 | msn.comSanofi: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV seasonJune 9, 2025 | finanznachrichten.deSanofi Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV seasonJune 9, 2025 | finanznachrichten.deTop global stories this week: UBS, Toyota Motor, Sanofi among major namesJune 8, 2025 | msn.comSanofi to Buy Blueprint for $9.1 Billion Equity ValueJune 2, 2025 | msn.comSanofi buys US biopharma group Blueprint in $9.1 billion dealJune 2, 2025 | msn.comSanofi: Finding Value In The Wake Of Itepekimab's DisappointmentMay 31, 2025 | seekingalpha.comSanofi, Regeneron shares nosedive after mixed Itepekimab resultsMay 30, 2025 | finance.yahoo.comStock Movers: Sanofi Down, M&G Up, Gap Down (podcast)May 30, 2025 | bloomberg.comSanofi, Regeneron’s Itepekimab Delivers Mixed Results in Late-Stage TrialsMay 30, 2025 | msn.comSanofi Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programsMay 29, 2025 | finanznachrichten.deSanofi: New Anthem from Girl Band Raises Awareness of Type 1 Diabetes After Research Highlights Silent StruggleMay 29, 2025 | finance.yahoo.comSanofi transfers vaccine production technology to VNVCMay 28, 2025 | msn.comSanofi exploring vaccine production in Vietnam with local partnerMay 27, 2025 | msn.comSanofi Sanofi completes acquisition of DR-0201May 27, 2025 | finanznachrichten.deC4X Discovery Holdings PLC: C4X Discovery receives latest milestone payment from SanofiMay 27, 2025 | finanznachrichten.deSanofi Redefines R&D strategy with AI: Vanguards of Health CareMay 22, 2025 | bloomberg.comNovavax Shares Jump After Long-Awaited FDA Approval of Its COVID-19 VaccineMay 21, 2025 | msn.comViz.ai, Sanofi and Regeneron to link for COPD managementMay 21, 2025 | msn.comNovavax Stock Soars on FDA Approval for New COVID-19 VaccineMay 19, 2025 | msn.comFrench finance minister criticises Sanofi's $20 billion USA investment decisionMay 15, 2025 | msn.comFrance's Sanofi to invest at least $20 billion in US through 2030May 14, 2025 | msn.comSanofi to Invest at Least $20 Billion in US Through 2030May 14, 2025 | msn.comDupixent approved in Singapore as the first-ever biologic medicine for patients with COPDMay 14, 2025 | finance.yahoo.comHawaii to receive $700M in drug settlement over blood thinnerMay 10, 2025 | yahoo.comDrugmakers to pay Hawaii $700M to settle lawsuit over blood thinnerMay 10, 2025 | yahoo.comHawaii enters $700M settlement agreement with pharmaceutical giantsMay 10, 2025 | msn.comHawaii secures $700 million settlement in lawsuit over blood-thinner PlavixMay 10, 2025 | msn.comOpella launches as independent companyMay 9, 2025 | msn.comNovavax swings to profit, says talks with FDA on COVID vaccine approval ongoingMay 8, 2025 | msn.comSanofi exec tells biotechs not to scrimp on clinical trial designMay 8, 2025 | finance.yahoo.comSpecial Le Mans livery for UA McLarenMay 2, 2025 | msn.comMuthoot Finance, Sanofi India to trade ex-dividend today; Ami Organics to trade ex-split todayApril 25, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Roche Holding AG (OtherRHHVF) and BioNTech SE (BNTX)April 25, 2025 | markets.businessinsider.comDividend Stocks in Focus: Sanofi India, Muthoot Finance trade ex-dividend; Ami Organics trades ex-splitApril 25, 2025 | msn.comRoche and Sanofi Seek Ways to Sidestep Potential Trump TariffsApril 25, 2025 | msn.comEuropean pharma companies push for higher drug prices in EU amid U.S. tariff threatsApril 24, 2025 | msn.comSanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchangedApril 24, 2025 | msn.comFDA Approves Dupixent for Chronic Spontaneous UrticariaApril 23, 2025 | usnews.comPharma bosses call for higher drug prices in EU to counter tariff threatApril 23, 2025 | ft.comSanofi Should Report Lower Profit, Sales Amid U.S. Policy Uncertainty -- Earnings PreviewApril 22, 2025 | marketwatch.comSanofi Canada is investing in care for the planetApril 22, 2025 | theglobeandmail.com1170% dividend per share: Record date this week - Do you own the BSE 500 stock?April 20, 2025 | msn.comMuthoot Finance, Sanofi India among 9 stocks going ex-dividend, split next week. Are they on your radar?April 20, 2025 | msn.comRegeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSUApril 18, 2025 | marketwatch.comEarendil Labs Sanofi Ink Global License Deal for Next Gen Autoimmune TherapiesApril 18, 2025 | msn.comPress Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDApril 15, 2025 | markets.businessinsider.comFinal dividend of Rs 55 announced by company after demerger; record date preponedApril 13, 2025 | msn.comSanofi announces publication of tolebrutinib Phase 3 data in NEJMApril 9, 2025 | markets.businessinsider.comDeutsche Bank Sticks to Their Hold Rating for Sanofi (SNYNF)April 7, 2025 | markets.businessinsider.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address SAN Media Mentions By Week SAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAN News Sentiment▼0.030.87▲Average Medical News Sentiment SAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAN Articles This Week▼46▲SAN Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Deutsche Bank Aktiengesellschaft News Today Bayer Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Genfit News Today Sartorius Stedim Biotech News Today Siemens Healthineers News Today Merck KGaA News Today Fresenius Medical Care News Today Sartorius Aktiengesellschaft News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:SAN) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
